Women's Health Diagnostics Market Size, Share & Trends Analysis Report By Type (Diagnostic Devices, Diagnostic Tests), By Application (Infectious Disease Testing, Sexually Transmitted Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Breast Cancer, Other Applications), By End-User (Home Care, Hospital and Diagnostics Centres) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Women's Health Diagnostics Market Size

The global women's health diagnostics market size was valued at USD 28.49 billion in 2025 and is projected to grow from USD 30.44 billion in 2026 to USD 51.76 billion by 2034, registering a CAGR of 6.86% during the forecast period from 2026 to 2034. North America dominated the women's health diagnostics market with a market share of 39.45% in 2025.

The medical speciality, known as "Women's health", is primarily concerned with diagnosing and treating illnesses and ailments that harm a woman's health. Ovarian cancer, breast cancer, cervical cancer, menopause, and pregnancy are just some of the Women's health conditions that can be screened for, tested for, or diagnosed using the Women's health diagnostic technique, which also includes monitoring these conditions. A wide variety of testing is available for diagnosing disorders affecting Women's health.

Medical diagnostics equipment, such as biopsy devices, imaging and monitoring systems, mammography systems, and others, detect cancer, remove obstructions, and take images of internal organs, which help screen and diagnose disease. Other diagnostics devices include: The diagnostic procedure comprises testing for breast cancer, testing for cervical cancer, prenatal genetic screening and testing for carriers, testing for pregnancy and ovulation, and testing for ovarian cancer. It is vital to make use of tests for screening for and detecting a variety of illnesses to avoid complications and improve one's quality of life. Tests of one's health are necessary to enhance one's health and avoid and treat significant disorders.

The increasing prevalence of chronic and lifestyle-related ailments, the growing number of imaging and diagnostic facilities, and the increased adoption of point-of-care and rapid diagnostic tests all contribute to the rapid expansion of the market.

Segmentation Analysis

By Type

Further, the segments are divided into sub-segments. The market is broken down into diagnostic devices and diagnostic tests based on types. Diagnostic devices are further classified into Biopsy Devices and Imaging & Monitoring systems. Diagnostic tests are divided into Breast Cancer Testing, PAP Smear (PAP) and HPV Test, Pregnancy Testing and Ovulation Testing and Other Diagnostic Tests.

In 2020, the diagnostic testing segment contributed the most to the market. The Women's health diagnostics market for tests is driven by an increase in the prevalence of various health-related disorders among women, such as cancer and infertility, as well as increased awareness about Women's health-related tests, high demand for point-of-care diagnostic testing, and the development of numerous diagnostic & imaging centres.

Request Customizationto receive a tailored report.

By Applications

Based on applications, the market is split into Infectious Disease Testing, Sexually Transmitted Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Breast Cancer and Other Applications.

By End-Users

According to end-users, the market is divided into Home Care and Hospital & Diagnostics Centres. The segment that contributes the most to the market is hospitals and diagnostic centres. The growth in breast and ovarian cancer incidence has resulted in a significant increase in hospitalizations.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Dominates the Global Market

Because of the increasing prevalence of cancer among women, increased incidence of lifestyle-related illnesses, high adoption of technologically sophisticated devices, new launches, and government initiatives, North America is likely to hold a significant market share. Key market players with technologically improved Women's health diagnostics products are expected to help drive regional expansion. Lia, for example, introduced the world's first flushable and biodegradable pregnancy test in March 2021. Lia's pregnancy tests are constructed entirely of plant fibres and contain no plastic, allowing them to biodegrade in just ten weeks.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific: Fastest Growing Region

Better healthcare infrastructure, increasing knowledge of Women's health conditions, and female engagement in the workforce are expected to boost the regional market's growth. The regulatory authority's clearance is also encouraging the market's expansion in the region. For example, Paragon Biosciences LLC formed Qlarity Imaging LLC in July 2019, intending to use artificial intelligence (AI) to improve medical results. Qlarity Imaging will create QuantX, one of the first FDA-approved computer-aided breast cancer diagnosis systems in radiography. The market is growing due to such approvals for technologically improved diagnostics products.

List of Key and Emerging Players in Women's Health Diagnostics Market